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Authors’ Reply  
 
Michael Bracken raised concerns about our umbrella review and meta-analysis, regarding 
two of the included studies: Andalib et al.1 and Morales et al.2.3 Both meta-analyses tested the 
association of antidepressant use - vs unexposed groups and autism spectrum disorder, but 
Morales et al2 addressed the overall association of antidepressant use (including SSRIs but 
without providing a subset of analysis of SSRIs) vs unexposed, while Andalib et al1 
addressed the specific association of SSRI use (not the other antidepressants) vs unexposed. 
To ensure that all the exposures analysed in our umbrella review were as specific as possible, 
we included Andalib et al1 and not Morales et al2. Morales et al.2, was rather included to 
assess the association between prepregnancy exposure to antidepressant use and autism 
spectrum disorder.  
Bracken highlighted potential intrinsic errors within the meta-analysis of Andalib et al.1. As 
we have acknowledged in the limitation paragraph of our study3, re-assessing primary errors 
in 119 eligible meta-analyses and their individual studies is out of the scope of umbrella 
reviews.4 We have re-analysed Andalib et al1 results after correcting for the biases 
highlighted by Bracken and found that the summary estimate was still statistically significant 
(OR 1.57, 95% CI 1.19 to 2.07). We have also re-analyzed the association of antidepressant 
use vs unexposed and autism spectrum disorder reported by Morales et al2 (digitally 
extracting data from their2 figure 2 -a procedure which was not originally planned in our 
protocol). The results were similarly graded as convincing evidence according to the 
established criteria (n of studies=11, OR 1.53, 95% CI 1.31 to 1.78, p=0.000000041, I2=33, 
95% prediction interval 1.07 to 2.19, Egger p=0.82, no signs of biases). Therefore there are 
no changes in the direction of our results.  
Certainly, the association of SSRI use vs unexposed and autism spectrum disorder is likely 
due to confounding, as we acknowledged (p.597) 3. We concluded that overall, our findings 
suggest that maternal psychiatric disorder might act as an independent risk factor for autism 
spectrum disorder3. Therefore, there are no errors in the interpretation of our results. 
 
All authors declare no competing interests.  
 
Jong Yeob Kim1, Paolo Fusar-Poli2,3,4, Jae Il Shin5* 
 
1. Yonsei University College of Medicine, Seoul, Republic of Korea. 
2. Early Psychosis: Interventions and Clinical-detection (EPIC) lab, Department of 
Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's 
College London, London, United Kingdom. 
3. OASIS service, South London and Maudsley NHS Foundation Trust, London, United 
Kingdom. 
4. Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy. 
5. Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of 
Korea. 
*Corresponding Author:  
Prof. Jae Il Shin, MD, PhD.  
Yonsei-ro 50, Seodaemun-gu, C.P.O. Box 8044, Department of Pediatrics, Yonsei University 
College of Medicine, Seoul 120-752, Korea 
E-mail: shinji@yuhs.ac 
 
References 
 
1. Andalib S, Emamhadi MR, Yousefzadeh-Chabok S, et al. Maternal SSRI exposure 
increases the risk of autistic offspring: A meta-analysis and systematic review. Eur 
Psychiatry 2017; 45: 161-6. 
2. Morales DR, Slattery J, Evans S, Kurz X. Antidepressant use during pregnancy and 
risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic 
review of observational studies and methodological considerations. BMC Med 2018; 16: 6. 
3. Kim JY, Son MJ, Son CY, et al. Environmental risk factors and biomarkers for 
autism spectrum disorder: an umbrella review of the evidence. Lancet Psychiatry 2019; 6: 
590-600. 
4. Fusar-Poli P, Radua J. Ten simple rules for conducting umbrella reviews. Evid Based 
Ment Health 2018; 21: 95-100. 
 
